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Abstract
Background: All-in-one station-based health monitoring devices are implemented in elder homes in Hong
Kong to support the monitoring of vital signs of the elderly. During a pilot study, it was discovered that the
systolic blood pressure was incorrectly measured during multiple weeks. A real-time solution was needed
to identify future data quality issues as soon as possible.
Methods: Control charts are an eective tool for real-time monitoring and signaling issues (changes) in
data. In this study, as in other healthcare applications, many observations are missing. Few methods are
available for monitoring data with missing observations. A data quality monitoring method is developed to
signal issues with the accuracy of the collected data quickly. is method has the ability to deal with miss-
ing observations. A Hotelling’s T-squared control chart is selected as the basis for our proposed method.
Findings: e proposed method is retrospectively validated on a case study with a known measurement
error in the systolic blood pressure measurements. e method is able to adequately detect this data qual-
ity problem. e proposed method was integrated into a personalized telehealth monitoring system and
prospectively implemented in a second case study. It was found that the proposed scheme supports the
control of data quality.
Conclusions: Data quality is an important issue and control charts are useful for real-time monitoring
of data quality. However, these charts must be adjusted to account for missing data that oen occur in
healthcare context.
Key words: Data quality; elderly; multivariate control charts; statistical quality control; vital sign moni-
toring
1 Background
Applications of Telehealth are growing due to the fast development of sensor technology. is has enabled the
development of relatively cheap and easy-to-use devices for (self-)evaluation of health indicators and well-
being. ese techniques have the potential to help current elder care providers to track vital signs, detect
physiological changes and predict health risks.
A pilot study has been conducted with an all-in-one station-based telehealth device in Hong Kong to help
track elder’s vital signs. is telehealth system is designed to provide computer-aided decision support for
clinicians and community nurses. It also enables them to easily monitor and analyze an elder’s vital signs and
well-being. For more details on this system see Yu and colleagues [1]. e present study involved two elder
care centers. In each center, elder’s volunteered to have their vital signs measured daily. For approximately
three months, trained and qualied research sta visited the centers and assisted the elders to accomplish
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the measurements on each measurement day (usually ve days a week). Vital signs were measured using a
commercial all-in-one station-based telehealth device (TeleMedCare, Health Monitor, TeleMedCare, Sydney,
Australia). Data is stored on a server, processed, analyzed and summarized into a report which is given to the
participants. e framework of this telehealth monitoring system is shown in the top panel of Fig. 1.
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Figure 1. Overview of the telehealth system, initial (top) and modified (boom).
In the pilot study, we found that the systolic blood pressure was incorrectly recorded during multiple
weeks. A structural data quality method was needed to ensure the accuracy of vital signs data collection.
e proposed data quality monitoring is implemented on a daily basis with a feedback loop to the telehealth
monitoring system, as illustrated in the lower panel of Fig. 1.
2 Methods
2.1 Settings
e elder care center where the systolic blood pressure was incorrectly measured (center A), is an elder day
care center situated in Kowloon, Hong Kong. e pilot study in center A had 24 participants and was con-
ducted in a period from 18.12.2017 to 07.03.2018. For each participant, ve vital signs were measured on each
measurement day; body temperature (BT) in degrees Celsius (◦C), systolic and diastolic blood pressure (SBP
and DBP) in millimeters of mercury (mm Hg), heart rate (HR) in number of beats per minute and peripheral
capillary oxygen saturation (SpO2) in percentages (%). We also included a second center (B) in our pilot study.
In center B there were 12 participants and the study ran from 01.03.2018 to 31.05.2018.
Fig. 2 gives an overview of the collected data, with the panels showing the vital signs for all participants
in center A (le) and center B (right) over the entire study period. Note that initial data is cleaned by deleting
improbable low values (i.e. outliers such as HR values of zero).
Close evaluation of Fig. 2 showed that starting from 12.02.2018 the SBP measurements in Center A do not
exceed 136, which is an abnormally low maximum value for SBP measurements. Retrospective investigation
revealed that the SBP measurement subsystem was accidentally and unknowingly limited to a maximum value
of 136. Hence, the collected data was capped for the rest of the study period. is data quality issue aected
all study participants in center A.
2.2 Choice of solution
In industrial applications, measurement system analysis (MSA) is performed to verify the accuracy of the
measurement system. MSA studies evaluate the repeatability and reproducibility of the measurement system.
And focus on the measurement system as a whole, including the measurement device, the people operating the
device as well as the environment [2]. A control chart is an associated tool oen used to visualize measurement
variability. In this paper, a data quality monitoring method based on a control chart is proposed to improve
the measurement accuracy of the data collected with the telehealth device.
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Figure 2. Boxplots of vital signs for elders in center A (le panel) and B (right panel).
A control chart is a statistical and visual tool. It is designed to prospectively signal change(s) in data
streams quickly. Control charts have been used in clinical seings [3], as well as for monitoring the quality of
cardiac surgery [4] and for monitoring in epidemiologic studies [5]. Overviews of control charts in healthcare
seings can be found in [6–8]. More specically, single patient univariate and multivariate monitoring of vital
signs is done in [9] who used deleted cases. Corne´lissen and colleagues [10] implement self-starting CUSUM
chart for vital signs monitoring. Sparks and colleagues [11] monitor vital sign trends of a single patient with
univariate exponential weighted moving average control charts and multiple vital signs with dynamic Biplots.
A control chart can also be used to monitor data quality by detecting changes in the data collection system
as timely as possible. Jones-Farmer and colleagues [12] provide a framework for control charts and data quality
monitoring. An error in the measurement system will show up as a change in the level of the vital sign(s).
Hence, a change in the level of vital sign(s) should be signaled.
A standard method used to monitor multiple variables is the Hotelling’s T -squared control chart, for
example see [3, 13]. As our all-in-one station-based telehealth device records multiple vital signs for each
participant we employed a Hotelling’s T -squared control chart. e choice for a multivariate, rather than
multiple univariate charts is motivated medically as vital signs are known to be correlated, for example SBP
and DBP [14]. In section 3 we verify this when we implement our case studies.
Each day we obtain data from multiple participants consecutively. In this work, we choose to treat the
data as grouped and obtain each day a data matrix containing all vectors of each individual (see section 2.4 for
details). We have three reasons to adopt this approach, rather than treating the data as individual data. Firstly,
it ts with the nature of our data collection: the data collected with the telehealth device were synchronized
daily aer all participants have undergone the measurements. Secondly, subgrouping our data helps with the
missing data issue. We create from the subgrouped data a vector of averages. Hence a matrix with a lot of
missing data is converted to a vector which is nearly always complete (see section 2.4 for details). irdly,
by subgrouping and averaging our data we create approximately independent and normally distributed data.
Finally, this leads to the convenience of monitoring a single control chart rather than one chart for each
participant.
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2.3 Missing data
In observational studies missing data are oen encountered (cf. [15]) and our study is no exception. We
encounter three types of missing data:
1. Not every vital sign is obtained daily.
2. Due to the type of elder care centers (day care) not all elders show up everyday for measurements.
3. Some elders join the program late or drop out early. Resulting into a long streams of missing data at
the start or end of the study period, which is a common situation in healthcare related studies [16].
Fig. 3 displays the varying number of obtained measurements (elders) over time for each vital sign and center.
is varying sample size shows that we have many missing data (without missing data all sample sizes would
be equal to 24 of center A and 12 for center B). Overall 10.3 % of the data is missing in center A. is percentage
varies across the vital signs from 1.7% up to 14.3%. Overall 3.9% of the data is missing in center B. e
percentage varies across the vital signs from 2.4% up to 6.3%.
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Figure 3. Sample size of vital signs for elders in center A (le panel) and B (right panel).
e literature [17] categorizes random missing data into two types: missing at random (MAR) and missing
completely at random (MCAR). e propensity of the MAR observations is due to the random in-out of the
elders and machining problems while observations in the data set are MCAR when a random event (e.g.,
typhoon) occurred and it is independent of the machining problems and presence of elders. From the available
information, it is assumed that the data is missing at random (MAR) in our study.
Traditional control charts are designed for complete data sets and it is dicult to run charts with missing
data. A solution to apply control charts to our incomplete dataset (addressed above as rst type of missing
data) with varying number of elders on each time point (afore-mentioned missing data type two and three)
is needed. One way to deal with missing data, in a healthcare seing, is to perform data imputation to “ll
in” the missing values. is approach is taken by [3] for the multivariate monitoring in a clinical seing and
by [18] who use imputation in a longitudinal study. e eect of using dierent imputation methods on the
performance of multivariate control charts is studied by [19] and [20]. Both studies concluded that control
Mahmood, Wienberg and Zwetsloot et al. 2019 • Monitoring data quality in the presence of missing data page 5
charts based on imputation methods provide beer performance as compared to control charts based on
deletion method. Currently, imputation is the selected method when missing observations are encountered.
However, [21] showed that imputation can only work properly when the percentage of missing data is small
and when we know this percentage a-priori. For our seings, data imputation is complicated because of the
afore-mentioned third type of missing data: late joining and dropping of elders. is is uncontrollable and the
number of late joiners is unknown a-priori. erefore, it is unknown a-priori what the percentage of missing
data will be.
Another way to deal with missing data is to use control charts for variable sample sizes (i.e. varying
number of participants per day). Previous studies proposed some methods for univariate data [22, 23] and
some for multivariate data [24, 25]. e laer methods assume that the varying sample sizes are known a-
priori and that the researcher controls the number of samples. Hence these methods are not straightforward
applicable here.
To the best of our knowledge, none of the existing control charts for variable sample sizes has the ability to
adequately deal with random varying sample sizes in a multivariate seing. Hence, a new method is developed
by adapting the Hotelling’s T -squared control chart to accommodate for missing data and random varying
sample size without the need to impute missing data.
2.4 Method development
For the purpose of method development, each participant is indexed by k (k = 1, 2, . . . , n), each vital sign
by j (j = 1, 2, . . . , p) and each day by i. Let Xijk be the measurement of person k for vital sign j on day i.
Hence, n vectors Xik ∈ Rp are obtained each day. Let µ denote the expectation and Σ the covariance matrix
of Xik
To monitor the data quality, the average value for each vital sign is computed by averaging over those
patients who showed up for measurement on day i. Giving vector X¯i of p elements (X¯i1, . . . , X¯ip)>. Here,
X¯ij is the average of nij ≤ n elders for vital sign j. e number of elders nij depends on the day i and
the vital sign j, and the changing nij allow us to model the missing data (nij). In Table 1 we show the data
structure, in this example elder #2 did not show up and therefore its data is missing as indicated by a star.
Also the rst vital sign for elder #1 was not recorded. e right column shows the corresponding sample sizes
for each vital sign in this example, the actual values of nij are displayed in Fig. 3.
Table 1. Data structure, missing data indicated by a *.
Xi1 Xi2 Xi3 · · · Xik · · · Xin X¯i ni
* * Xi13 · · · Xi1k · · · Xi1n → X¯i1 ni1
Xi21 * Xi23 · · · Xi2k · · · Xi2n → X¯i2 ni2
...
...
...
...
...
...
...
...
...
...
Xip1 * Xip3 · · · Xipk · · · Xipn → X¯ip nip
In section 2.3, we argued that our data is MAR. Under this MAR assumption it follows that µX¯ = µ and
aer some derivation (see Appendix), we also have
ΣX¯i = Wi Σ. (1)
Here,  denotes element wise matrix multiplication, which is also known as Hadamard multiplication and
Wi is a matrix weighting the elements of Σ according to the number of paired observations (participants)
available for measurement on day i. e matrix Wi is a p× p matrix dened as
Wi =
[∣∣Uij ∩ Uij′ ∣∣
nijnij′
]
j,j′=1,...,p
. (2)
Here, Uij is the set of participants for whom a measurement of vital sign j on day i is available and nij = |Uij |
is the number of elements in Uij , i.e. the number of participants. For example, if on day i two participants,
say #1 and #3, showed up to measure vital sign j = 2 then Ui2 = {1, 3} and ni2 = 2. Note that under
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complete observations, it follows that nij = n and hence Wi = [1/n]. It is possible that nij = 0 when one
of the vital signs j is not measured for all participants on the day i. is happened on the nal two days in
center A for SBP and DBP. To account for this we reduce the dimension of our monitoring statistic. is will
be discussed in detail below.
e design of a Hotelling’s T -squared monitoring statistic is T 2i = (X¯i − µ)>Σ−1X¯i (X¯i − µ). In order to
compute this statistic, estimates of the unknown parametersµ and ΣX¯i are needed. For this we select the rst
19 days from each study for estimation (as the Phase I data set). To avoid biased estimates due to outliers in
the data (see Fig. 2), estimates of the mean vector µˆ and the covariance matrix Σˆ are obtained using a robust
estimation method. Various robust methods have been evaluated [26] for the Hotelling’s T -squared control
chart. Here, the orthogonalized Gnanadesikan–Keenring (OGK) estimation method [27] is used, because
it provides positive denite and approximately ane equivariant robust estimates. e OGK estimators are
obtained using the R-package rrcov [28]. Recall that ΣˆX¯i = Wi  Σˆ by using the OGK estimator we obtain
Σˆ based on the Phase I data which we clubbed and omied incomplete cases. We argued that the data are
missing MAR, therefore this should yield a unbiased and consistent estimator of Σ and hence also of ΣX¯i .
e nal monitoring statistic now becomes:
T 2i = (X¯i − µˆ)>(Wi  Σˆ)−1(X¯i − µˆ) (3)
and the control chart signals, when T 2i exceeds the Upper Control Limit (UCL). Whenever T 2i exceeds the
UCL, a signal is observed. is signal should be investigated and appropriate corrective action should be
taken. Usually, for multivariate control charts, a decomposition method is used to determine which variables
are responsible for the signal. For our proposed Hotelling’s T -squared control chart, the Mason-Young-Tracy
(MYT) decomposition method [29] was adopted. In the MYT decomposition, T 2 statistics are calculated for all
possible subsets of vital signs and ploed against the respective UCL to identify the vital sign or combination
of vital signs, which give a signal.
e UCLs for all possible combinations of vital signs are obtained by using the following simulation pro-
cedure:
1. Generate a data set of m × n¯ vectors Xi ∼ N (µˆ, Σˆ). Here m represents the number of days of data
used to estimate the mean and covariance. And n¯ = 1mp
m∑
i=1
p∑
j=1
nij is dened as the overall average
number measurements for the vital signs obtained on a day.
2. Based on this data set, compute the robust mean vector µˆOGK and covariance matrix ΣˆOGK by using
the OGK estimation method.
3. Generate vector X¯i ∼ N (µˆ, Σˆ/n¯). Compute the Hotelling’s T -squared statistic as T 2i = (X¯i −
µˆOGK)>Σˆ
−1
OGK(X¯i − µˆOGK).
4. Repeat step 3 for 10,000 times and select the (1− α)-th quantile of T 2 as UCL.
Repeat steps 1-4, 100 times and calculate the nal UCL as the average of all obtained control limits from step
4. For both center A and B, m equals 19. For center A n¯ equals 20 and for center B n¯ equals 9. From the
simulations, we get UCL = 17.31 for center A and UCL = 18.59 for the center B. ese UCLs are obtained
by xing the false alarm rate α = 0.02, which implies a false alarm every 50 days on average. To obtain these
UCLs, we have assumed complete data in our simulation procedure. is is a simplication to facilitate easy
simulation. We have also implemented the simulation procedure with varying missing data scenarios. e
obtained UCLs for these scenarios are all comparable to the limits discussed above and they dier maximally
at a level of 5%.
One additional modication to the chart (reduction in vital signs) is necessary. Whenever a vital sign is
not measured for at least one participant, one element in X¯i will be missing. e corresponding row from
(X¯i − µ) is then removed, the corresponding row and column from ΣX¯i are also removed and nally, the
control limit is adjusted for that time instance. For example, in center A, only three vital signs are measured
on the last two days of the study (see Fig. 3), so a reduced UCL is ploed at 13.29.
Finally, before this chart can be implemented, it is important to verify that the data comply with the
important underlying assumptions of our method. In this study, it is assumed that the average vector X¯i
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follows a multivariate independent normal distribution with a mean vector µX¯i and covariance matrix ΣX¯i .
Note that we assume normality for the average, this is rather convenient, as vital signs will not be normally
distributed on an individual basis. However for mean vectors we can expect that normality is a reasonable
assumption. We verify this assumption by performing several multivariate normality tests; Mardia’s test [30]
and Henze-Zirkler’s multivariate normality test [31] implemented in the R-package MVN [32]. Next we need
to consider independence. It is known that vital signs show autocorrelation [33]. For our application we
consider the average vector, any autocorrelation in the individual vital signs will decline by averaging over
observations. We verify that the average vector is approximately independent over time using the standard
acf function in R. A third important step we take is the estimation of our µ and Σ matrix. We use the robust
OGK estimator using clubbed complete cases data for the rst 19 days. Here we assume that this estimator is
unbiased and consistent even though we use a subset of data. It is dicult to check this empirically, however
the authors [27] of the OGK estimator state in their paper that this estimator is robust to various types of
outliers. Ideally we would prefer an Phase I estimator that is also shown to be robust to missing data and
deviations from normality. However, to our knowledge an estimator for the variance-covariance matrix that
can handle outliers, missing data as well as slight deviations from normality in sub grouped data does not
(yet) exist. We welcome new research on this issue. We compared all existing estimations methods and from
both a empirical as well as theoretical point of view we believe the OGK estimator served our purpose best.
3 Findings
Our control chart is designed to detect data quality issues. A signal may show that the SBP measurement sub-
system is capped (the reason for this project). However, a signal can also be caused by changes in individual
participant’s vital signs. is signal than may point towards the need for medical assistance (rather than
measurement system calibration). In the elder care centers, well trained personal takes care of the elders.
In this project, we consulted with them aer any signal caused by individual vital sign levels. A separate
project is being conducted to design a monitoring system for individuals. However, before we can monitor
individual’s vital signs for changes in health, we need to ensure that the collected data is accurate. at is
where our proposed method is applied. e proposed monitoring method is rst validated on center A and
next prospectively run on center B to monitor the data quality.
3.1 Retrospective implementation for center A
Next the proposed method is retrospectively implemented for center A. e rst 19 days, from 19.12.2017 to
16.01.2018, are used to obtain the OGK estimates:
µˆ =

µˆBT
µˆSBP
µˆDBP
µˆHR
µˆSpO2
 =

35.93
131.31
67.55
73.38
97.94

and
Σˆ =

0.10 -0.01 -0.06 0.28 0.00
-0.01 254.92 22.33 -48.58 0.56
-0.06 22.33 87.13 3.54 -0.04
0.28 -48.58 3.54 130.38 5.18
0.00 0.56 -0.04 5.18 2.36
 .
Before we plot the proposed control chart, we validate the most important assumptions of normality and
independence over time. We also study the correlation between the vital signs to motivate the multivariate
nature of our method. We found no evidence of deviation from multivariate normality. In addition we compute
the autocorrelation function and found no evidence of signicant autocorrelation between the mean levels of
each of the vital signs. Finally, we looked at the correlation matrix, standardized from the variance-covariance
matrix above, and concluded that multiple pairs of vital signs are correlated as validated by Bartle’s test of
sphericity [34] (p-value < 0.0001).
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Next, the control chart is ploed to monitor the data quality in case A. e Hotelling’s T -squared statistics
are calculated by using Equation (3) and ploed against the UCL=17.31 in Fig. 4.
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Figure 4. Hotelling’s T -squared chart for center A.
e following catches the eye:
• e rst four signals are observed in the interval from 21.12.2017 to 29.12.2017. e MYT decomposition
method identies all signals as caused by changes in the mean of the DBP measurements.
• e next four signals are observed in the interval from 10.01.2018 to 02.02.2018. MYT decomposition
method classies the 5th, and 7th signal as driven by variation in the DBP and BT measurements. e
6th signal, on 25.01.2018, is due to the variation in SpO2 measurements. e 8th signal, on 02.02.2018,
is due to variation in DBP.
• e signals from 20.02.2018 until 02.03.2018 were expected as these signals are due to the capped mea-
surements of SBP. However, the signal is delayed by four days. e MYT decomposition indicates that
apart from SBP the BT also inuenced the signal.
• In the last two days, two signals are observed. e MYT decomposition indicated a decrease in the
means of the BT measurements.
Overall, the collected data are not stable in this pilot study. Many issues, especially with the SBP mea-
surement are discovered. Hence, it is necessary to implement a data quality monitoring method into the
telehealth system (Fig. 1). Such a method can help to detect undesirable situation as soon as possible so that
appropriate action can be taken. Apart from the monitoring scheme, other actions such as training of sta
and standardized working procedures were also applied to ensure repeatable and reproducible measurements.
3.2 Prospective implementation for center B
To evaluate the usefulness of our developed Hotelling’s T -squared control chart, we prospectively implement
the developed control chart for center B. ereby, we verify in real-time, whether the telehealth system is
functioning normally. e data collection started on 02.03.2018 and the rst week of observations are used to
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estimate the parameters (µˆ and Σˆ). A signal was observed on 09.03.2018, aer careful investigation and MYT
decomposition, it was discovered that the DBP measurements were set to a maximum level on that day. is
issue was solved by adjusting the telehealth device.
e data collection was continued in the subsequent weeks and the Hotelling’s T -squared control chart,
based on re-estimated parameters was ploed. is iterative method was continued until m = 19 days of
data were collected. e corresponding OGK estimates for the mean vector and covariance matrix are
µˆ =

µˆBT
µˆSBP
µˆDBP
µˆHR
µˆSpO2
 =

36.83
133.96
69.80
71.11
96.96

and
Σˆ =

0.12 0.90 -0.06 0.55 0.23
0.90 328.42 29.28 60.74 5.59
-0.06 29.28 69.99 27.13 -0.39
0.55 60.74 27.13 184.52 0.29
0.23 5.59 -0.39 0.29 3.34
 .
Similarly, as in Case A, we have validated assumptions; we found no statistical signicant dierence from
normality nor any evidence for autocorrelation. Furthermore, some pairs of vital signs show correlation
(Bartle’s test p-value< 0.0001). e Hotelling’sT -squared control chart for the full study period is displayed
in Fig. 5.
A second signal was observed on 13.04.2018, aer careful investigation the signal can be aributed to a
very high HR for a single participant. Another signal was observed on 29.05.2018, the MYT decomposition
method identied that the cause for the signal is an unusual high SBP level and an unusual low SpO2 level.
Overall, the implementation of the data quality monitoring method provides a timely indication of data
quality issues which may leads to adjustment of the telehealth system and a decrease in the wastage of re-
sources.
4 Discussion and conclusion
Telehealth applications provide many opportunities for innovations in healthcare. However, the accuracy and
reliability of measured data may be challenging to guarantee when various people, especially non-medical
experts, perform the measurements [35–37]. ere are many ways to validate and guarantee data accuracy,
such as training people and calibration of the measurement system. In this article, we set forth an additional
check to verify the real-time quality of measured data. A Hotelling’s T -squared control chart is designed,
which is modied to deal with missing data. Aer testing the proposed method on a case study with known
data quality issues, the control chart is prospectively implemented on a second case study. In the second
study, a data quality issue is detected aer one week, which was timely solved. Hence, a regular focus on the
data quality helps to ensure the validity and accuracy of the collected measurements and a quick feedback to
the data quality monitoring system is essential to solve problems on-time.
Data monitoring is also important on an individual level and more comprehensive models are needed
to deal with the heterogeneity of individuals. An individual monitoring tool can be helpful to detect health
changes for each elder separately. However, before this can be done, the data has to be accurate. e developed
method for data quality monitoring can thus be seen as a rst step before monitoring the health individually.
e focus is on handling the variable sample sizes, in our application due to MAR type missing data. Our
approach can also be applied to other scenarios with missing data where monitoring is required. It would be
useful if future research would compare the proposed method to existing methods for monitoring data with
missing observations, such as the imputation method.
EWMA or CUSUM control charts are generally quicker in detection of a failure mode than a Hotelling’s
T -squared control chart. erefore, a possible extension for future research could be a multivariate version
of the CUSUM procedure with the dynamic probability control limits developed by [22].
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Figure 5. Hotelling’s T -squared chart for center B.
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Appendix
In this appendix, we provide the derivation of the adjustment factor Wi as used in equation (1): ΣX¯i =
Wi Σ. As stated in equation (2), Wi is equal to
Wi =
[∣∣Uij ∩ Uij′ ∣∣
nijnij′
]
j,j′=1,...,p
.
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As discussed in section 2.4, Uij is the set of elders who showed up for measureing their vital sign j on day i
and dene nij = |Uij |. Recall that the matrix ΣX¯i is the covariance matrix for the random mean vector X¯i
which is dened as
X¯i =
 1
nij
∑
k∈Uij
Xijk

j=1,...,p
.
Following a similar set-up as [25], we derive the covariance between any two elements j and j′ of X¯i as
Cov
(
X¯ij , X¯ij′
)
= Cov
 1
nij
∑
k∈Uij
Xijk,
1
nij′
∑
k′∈Uij′
Xij′k′

= 1
nijnij′
∑
k∈Uij
∑
k′∈Uij′
Cov
(
Xijk, Xij′k′
)
.
We assume independence of observations between individual elder, i.e., Cov
(
Xijk, Xij′k′
)
= 0 whenever
k 6= k′. Now it follows that
Cov
(
X¯ij , X¯ij′
)
= 1
nijnij′
∑
k∈Uij∩Uij′
Cov
(
Xijk, Xij′k
)
=
∣∣Uij ∩ Uij′ ∣∣
nijnij′
Cov
(
Xij , Xij′
)
=
∣∣Uij ∩ Uij′ ∣∣
nijnij′
σjj′ .
Alternatively, we can write
ΣX¯i =
[∣∣Uij ∩ Uij′ ∣∣
nijnij′
σjj′
]
j,j′=1,...,p
.
Where Wi =
[ ∣∣Uij ∩ Uij′ ∣∣ /nijnij′], can be interpreted as the weighting matrix which takes the number of
observed data points into account. Hence, the covariance matrix of X¯i is equal to
ΣX¯i = Wi Σ
where, is the Hadamard product, which denotes element wise matrix multiplication and Σ is the covariance
matrix of the individual data.
